Dividends hey.....
With >1000 patents and so much research going on MSB could involve themselves with one or two main plays but then partner out most of the other ones to minimise their own spend and speed trial progress for many diseases at once. Plus collecting royalties from the possibly hundreds of other companies infringing on our patents at the same time.
This is certainly a possible outcome, but that first approval is required to get the snowball moving.
I really wonder if MSB will be able to cope with off label use after approval as well.
Worse problems to have.
Dividends hey.....With >1000 patents and so much research going...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.060(5.85%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.10 | $1.02 | $6.406M | 6.038M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 313712 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
0.060 ( 5.29 %) |
||||
| Open | High | Low | Volume | ||
| $1.03 | $1.10 | $1.02 | 928883 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| MSB (ASX) Chart |